SynDRA canonical compound SYN0000472 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|---|
| Approval status | Approved · Rx/OTC |
| Primary target(s) | CYP3A5 |
| Mechanism of action | DNA alkylating agent |
| Indication | acute lymphoblastic leukemia (ALL) | acute myeloid leukemia (AML) | breast cancer | Burkitt's lymphoma | chronic lymphocytic leukemia (CLL) | chronic myeloid leukemia (CML) | Hodgkin's lymphoma | multiple myeloma | neuroblastoma | ovarian cancer | retinoblastoma | small lymphocytic lymphoma (SLL) | true histiocytic lymphoma (THL) |
| Disease area | hematologic malignancy | oncology |